The synthesis of novel spirocyclic N-aryl-substituted 2-thiopyrimidine-4,6-diones

Authors

  • N. I. Kobyzhcha "V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Science of Ukraine", Ukraine
  • V. M. Holovatiuk "V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Science of Ukraine", Ukraine https://orcid.org/0000-0001-5454-8491
  • V. V. Rozhkov "Institute of Organic Chemistry of the National Academy of Science of Ukraine", Ukraine
  • V. I. Kashkovsky "V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Science of Ukraine", Ukraine

DOI:

https://doi.org/10.24959/ophcj.19.962

Keywords:

nitrogen heterocycles, spiro-annulation, thiopyrimidine-4, 6-dione, metathesis, Grubbs catalyst

Abstract

A convenient and efficient method for the synthesis of new unsaturated spiro-annulated N-aryl-4,6-dioxopyrimidine-2-thione derivatives has been developed. The resulting compounds can be potential biological active molecules or precursors for further chemical modification.

Aim. To develop the methods for the synthesis of new unsaturated spiro-annulated 2-thiopyrimidine-4,6-dione derivatives, which can be used as potentially biological active molecules or precursors for their formation.

Results and discussion. By condensation of N-aryl-substituted thioureas and allylmalonic acid using acetic anhydride or acetyl chloride the series of 5-allyl-substituted 2-thiopyrimidinediones has been synthesized. Their further alkylation with allyl bromide or metallyl chloride led to formation of 5,5-dialkenyl derivatives, which were converted to the corresponding unsaturated spirocyclic dioxopyrimidine-2-thiones by ring-closing metathesis. 

Experimental part. The synthesis of the starting compounds and title products was performed by preparative chemical methods, TLC and column chromatography, elemental analysis, NMR-spectroscopy.

Conclusions. The efficient three-step synthetic route of new unsaturated spiro-annulated N-aryl-4,6-dioxopyrimidine-2-thione derivatives from the starting N-arylsubstituted thioureas and allylmalonic acid has been developed. The spiro-annulated products obtained can find application in biological and pharmaceutical science or as starting substrates for further chemical modification.

Downloads

Download data is not yet available.

References

  1. Girgis, A. S., Farag, H., Ismail, N. S. M., & George, R. F. (2011). Synthesis, hypnotic properties and molecular modeling studies of 1,2,7,9–tetraaza–spiro[4.5]dec–2–ene–6,8,10–triones. European Journal of Medicinal Chemistry, 46 (10), 4964–4969. https://doi.org/10.1016/j.ejmech.2011.07.058
  3. Cope, Arthur C. (1955). Spiro barbituric acids. US Pat. Appl., 2725380 A ; declared 13.08.1949 ; published 29.11.1955.
  5. Lee, W. C. (1953). Comparative depression of several short acting barbiturates and spiro–barbiturates. The Japanese Journal of Pharmacology, 2, 123–126. https://doi.org/10.1254/jjp.2.123
  7. Osman, A. N., Kandeel, M. M., Saidand, M. M., Ahmed, E. M. (1996). Synthesis and anticonvulsant activity of certain spiro compounds derived from barbituric and thiobarbituric acids. Ind. J. Chem, 35B, 1073–1078. https://doi.org/10.1002/chin.199652179
  9. Behera, R. K., Behera, A., Pradhan, K., Pati, R. A., Patra, M. (2006). Studies on spiroheterocycles Part–II : Heterocyclization of the spiro compounds containing cyclohexanone and thiobarbituric acid with different bidentate nucleophilic reagents. Synth. Commun, 36, 3729–3742. https://doi.org/10.1080/00397910600946231
  11. Bhaskarachar, R. K., Revanasiddappa, V. G., Hegde, S., Balakrishna, J. P., Reddy, S. Y. (2015). Design, synthesis and anticancer activity of functionalized spiro–quinolines with barbituric and thiobarbituric acids. Med. Chem. Res., 24, 3516–3528. https://doi.org/10.1007/s00044-015-1408-7
  13. Behera, R. K., Behera, A. K., Pradhan, R., Patra, M. (2006). Studies on spiroheterocycles part–I : Installation of biologically active heterocyclic nuclei into spiro compounds derived from cyclohexanone and diphenyl thiobarbituric acid. Ind. J. Chem., 45B, 933–942.
  15. Ziarani, M., Asadi, S., Faramarzi, S., Amanlou M. (2015). Green Synthesis and Urease Inhibitory Activity of Spiro–Pyrimidinethiones / Spiro–Pyrimidinones–Barbituric Acid Derivatives. Iran. J. Pharm. Res., 14 (4), 1105–1114.
  17. Goel, B., Sharma, S., Bajaj, K., Bansal, D., Singh, T., Malik, N., … Kumar, A. (2005). Synthesis and CNS depressant of newer spirobarbiturates, 67, 194–199.
  19. Cope, A., Kovacic, P., Burg, M. (1949). Spirobarbituric Acids Containing a Six–membered Carbocyclic Ring. J. Am. Chem. Soc., 71 (11), 3658–3662. https://doi.org/10.1021/ja01179a023
  21. Kotha, S., Deb, A., Kumar, R. (2005). Spiro–annulation of barbituric acid derivatives and its analogs by ring–closing metathesis reaction. Bioorg. Med. Chem. Lett., 15 (4), 1039–1043. https://doi.org/10.1016/j.bmcl.2004.12.034
  23. Kotha, S. and Deb, A. (2008). Design and synthesis of spiro–heterocycles by ring–closing metathesis. Ind. J. Chem., 47B, 1120–1134.
  25. Kobyzhcha, N. I., Holovatiuk, V. M., Bezugly, Yu.V., Kashkovsky, V. I. (2013). Synthesis of new N,N’–disubstituted 5–spirocyclopenten–3–yl 2,4,6–trioxyhexahydropy–rimidines. Journal of Organic and Pharmaceutical Chemistry, 11 (4), 42–47. https://doi.org/10.24959/ophcj.13.770
  27. Katritzky, A. R., Kirichenko, N., Rogovoy, B. V., Kister, J., Tao, H. (2004). Synthesis of mono– and N,N–disubstituted thioureas and N–acylthioureas. Synthesis, 11, 1799–1805. https://doi.org/10.1055/s-2004-829127
  29. Kingsbury, J. S., Harrity, J. P., Bonitatebus, P. J., Hoveyda, A. H. (1999). A Recyclable Ru–Based Metathesis Catalyst. J. Am. Chem. Soc, 121 (4), 791–799. https://doi.org/10.1021/ja983222u

Downloads

Published

2019-03-13

How to Cite

(1)
Kobyzhcha, N. I.; Holovatiuk, V. M.; Rozhkov, V. V.; Kashkovsky, V. I. The Synthesis of Novel Spirocyclic N-Aryl-Substituted 2-Thiopyrimidine-4,6-Diones. J. Org. Pharm. Chem. 2019, 17, 20-27.

Issue

Vol. 17 No. 1(65) (2019)

Section

Original Researches

License

Copyright (c) 2019 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).